NCT06427200View on ClinicalTrials.gov

Efficacy and Safety of Lactoferrin in Heart Failure Patients

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

July 31, 2024

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2027

Conditions
Heart Failure With Reduced Ejection Fraction
Interventions
DRUG

oral Iron

oral iron once daily during or after meals as add-on therapy for 12 weeks.

DRUG

Lactoferrin

lactoferrin twice daily before meals as add-on therapy for 12 weeks.

DRUG

lactoferrin and oral iron

lactoferrin twice daily before meals and oral iron once daily during or after meals as add-on therapy for 12 weeks.

All Listed Sponsors
lead

Cairo University

OTHER

NCT06427200 - Efficacy and Safety of Lactoferrin in Heart Failure Patients | Biotech Hunter | Biotech Hunter